Yonghe Medical Group Co., Ltd. (HKG:2279)
Hong Kong · Delayed Price · Currency is HKD 3.020
+0.160 (5.59%)
At close: Aug 6, 2025, 4:00 PM HKT
Yonghe Medical Group Revenue
In the year 2024, Yonghe Medical Group had annual revenue of 1.80B CNY with 1.53% growth. Yonghe Medical Group had revenue of 904.30M in the half year ending December 31, 2024, with 36.06% growth.
Revenue
1.80B CNY
Revenue Growth
+1.53%
P/S Ratio
0.77
Revenue / Employee
508.45K CNY
Employees
3,549
Market Cap
1.48B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.80B | 27.24M | 1.53% |
| Dec 31, 2023 | 1.78B | 364.47M | 25.80% |
| Dec 31, 2022 | 1.41B | -755.79M | -34.85% |
| Dec 31, 2021 | 2.17B | 530.28M | 32.37% |
| Dec 31, 2020 | 1.64B | 413.82M | 33.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 35.81B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |